Please Enable Cookies to Continue
Please enable cookies in your browser to experience all the personalized features of this site, including the ability to apply for a job.
Here are our current job openings. Please click on the job title for more information, and apply from that page if you are interested.
Current Dendreon Employees: Please apply using the internal career site available through the intranet.
The system cannot access your location for 1 of 2 reasons:
- Permission to access your location has been denied. Please reload the page and allow the browser to access your location information.
- Your location information has yet to be received. Please wait a moment then hit [Search] again.
Click column header to sort
PLEASE NOTE:THE CANDIDATE FOR THIS ROLE MUST RESIDE IN FLORIDA. TERRITORY COVERAGE IS THE SOUTHEAST.
Who we are.
Dendreon is making the battle against cancer personal. Our flagship product...
Who we are:
At Dendreon, we’re revolutionizing cancer care through personalized immunotherapy. Our pioneering treatment, PROVENGE® (sipuleucel-T), was the first FDA-approved immunotherapy for advanced prostate cancer. By activating a patient’s own immune system, we empower the body to fight back—offering real hope to those who need it most.
Who we are:
At Dendreon, we’re revolutionizing cancer care through personalized immunotherapy. Our pioneering treatment, PROVENGE® (sipuleucel-T), was the first FDA-approved immunotherapy for advanced prostate cancer. By activating a patient’s own immune system, we empower the body to fight back—offering real hope to those who need it most.
Who we are:
At Dendreon, we’re revolutionizing cancer care through personalized immunotherapy. Our pioneering treatment, PROVENGE® (sipuleucel-T), was the first FDA-approved immunotherapy for advanced prostate cancer. By activating a patient’s own immune system, we empower the body to fight back—offering real hope to those who need it most.
Who we are.
Dendreon is making the battle against cancer personal. Our flagship product PROVENGE® (sipuleucel-T), was the first FDA approved immunotherapy for the treatment of metastatic castrate resistant prostate cancer and is made from the patient's own immune cells.
If you are looking to positively impact...
Who we are.
Dendreon is making the battle against cancer personal. Our flagship product PROVENGE® (sipuleucel-T), was the first FDA approved immunotherapy for the treatment of metastatic castrate resistant prostate cancer and is made from the patient's own immune cells.
If you are looking to positively impact...
Who we are.
Dendreon is making the battle against cancer personal. Our flagship product PROVENGE® (sipuleucel-T), was the first FDA approved immunotherapy for the treatment of metastatic castrate resistant prostate cancer and is made from the patient's own immune cells.
